CONMED Property, Plant, and Equipment 2010-2024 | CNMD

CONMED property, plant, and equipment from 2010 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
CONMED Annual Property, Plant, and Equipment
(Millions of US $)
2023 $121
2022 $116
2021 $109
2020 $111
2019 $119
2018 $113
2017 $116
2016 $122
2015 $125
2014 $133
2013 $139
2012 $139
2011 $139
2010 $141
2009 $144
CONMED Quarterly Property, Plant, and Equipment
(Millions of US $)
2024-06-30 $117
2024-03-31 $118
2023-12-31 $121
2023-09-30 $120
2023-06-30 $117
2023-03-31 $115
2022-12-31 $116
2022-09-30 $114
2022-06-30 $112
2022-03-31 $109
2021-12-31 $109
2021-09-30 $109
2021-06-30 $108
2021-03-31 $109
2020-12-31 $111
2020-09-30 $112
2020-06-30 $113
2020-03-31 $114
2019-12-31 $119
2019-09-30 $117
2019-06-30 $117
2019-03-31 $117
2018-12-31 $113
2018-09-30 $114
2018-06-30 $115
2018-03-31 $116
2017-12-31 $116
2017-09-30 $117
2017-06-30 $118
2017-03-31 $120
2016-12-31 $122
2016-09-30 $123
2016-06-30 $125
2016-03-31 $127
2015-12-31 $125
2015-09-30 $131
2015-06-30 $132
2015-03-31 $133
2014-12-31 $133
2014-09-30 $136
2014-06-30 $138
2014-03-31 $139
2013-12-31 $139
2013-09-30 $139
2013-06-30 $138
2013-03-31 $138
2012-12-31 $139
2012-09-30 $140
2012-06-30 $141
2012-03-31 $141
2011-12-31 $139
2011-09-30 $140
2011-06-30 $141
2011-03-31 $141
2010-12-31 $141
2010-09-30 $142
2010-06-30 $142
2010-03-31 $143
2009-12-31 $144
2009-09-30 $146
2009-06-30 $148
2009-03-31 $147
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.343B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.939B 18.14
McKesson (MCK) United States $66.345B 18.25
Cardinal Health (CAH) United States $26.957B 14.91
West Pharmaceutical Services (WST) United States $22.428B 43.73
Cooper (COO) United States $22.013B 31.33
Labcorp (LH) United States $19.078B 15.89
Align Technology (ALGN) United States $18.899B 36.51
Henry Schein (HSIC) United States $9.181B 16.81
Merit Medical Systems (MMSI) United States $5.746B 30.37
DENTSPLY SIRONA (XRAY) United States $5.414B 14.52
Patterson (PDCO) United States $1.936B 10.21
STAAR Surgical (STAA) United States $1.544B 69.76
Lifevantage (LFVN) United States $0.127B 17.48
Pro-Dex (PDEX) United States $0.086B 41.13